Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sujata Bhoi"'
Autor:
Sujata Bhoi, Panagiotis Baliakas, Diego Cortese, Mattias Mattsson, Marie Engvall, Karin E. Smedby, Gunnar Juliusson, Lesley-Ann Sutton, Larry Mansouri
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Externí odkaz:
https://doaj.org/article/496a1fc9990a4767babcb6a5d78f2086
Autor:
Sònia Tugues, Francis Roche, Oriol Noguer, Anna Orlova, Sujata Bhoi, Narendra Padhan, Peter Akerud, Satoshi Honjo, Ram Kumar Selvaraju, Massimiliano Mazzone, Vladimir Tolmachev, Lena Claesson-Welsh
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107483 (2014)
Histidine-rich glycoprotein (HRG) is implicated in tumor growth and metastasis by regulation of angiogenesis and inflammation. HRG is produced by hepatocytes and carried to tissues via the circulation. We hypothesized that HRG's tissue distribution a
Externí odkaz:
https://doaj.org/article/e3f723a623e34db3b807cc79329701a1
Autor:
Martí Duran-Ferrer, Larry Mansouri, Ferran Nadeu, Guillem Clot, Sujata Bhoi, Lesley Ann Sutton, Panagiotis Baliakas, Sara Ek, Venera Kuci Emruli, Karla Plevova, Zadie Davis, Hanna Goransson-Kultima, Anders Isaksson, Karin E. Smedby, Gianluca Gaidano, Anton W. Langerak, Frederic Davi, Davide Rossi, David Oscier, Sarka Pospisilova, Maria Karypidou, Andreas Agathangelidis, Wolfgang Huber, Junyan Lu, Thorsten Zenz, Julio Delgado, Armando Lopez-Guillermo, Paolo Ghia, Elías Campo, Kostas Stamatopoulos, Richard Rosenquist, José I. Martín-Subero
Publikováno v:
Blood. 140:1800-1802
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Cancer Research. 83:2691-2691
Background: Fostroxacitabine bralpamide (fostrox) is an orally administered liver-targeted troxacitabine-based nucleotide prodrug currently undergoing phase 1/2a clinical trial in advanced hepatocellular carcinoma (HCC), in combination with pembroliz
Autor:
Frederic Davi, Davide Rossi, Sara Ek, Chrysoula Belessi, Matthias Ritgen, Andigoni Malousi, Nikos Papakonstantinou, Gianluca Gaidano, Larry Mansouri, Karla Plevová, Anastasia Hadzidimitriou, Šárka Pospíšilová, Maria Tsagiopoulou, Kostas Stamatopoulos, Martí Duran-Ferrer, Maria Gounari, Sujata Bhoi, Venera Kuci‐Emruli, Christiane Pott, Stamatia Laidou, Theodoros Moysiadis, Paolo Ghia, José I. Martín-Subero, Richard Rosenquist, Fotis Psomopoulos, Konstantinos Pasentsis, Zadie Davis, David Oscier, Stavroula Ntoufa, Niki Stavroyianni, Despoina Papazoglou
Publikováno v:
International journal of cancer
International Journal of Cancer
International Journal of Cancer
Chronic lymphocytic leukemia (CLL) stereotyped subsets #6 and #8 include cases expressing unmutated B cell receptor immunoglobulin (BcR IG) (U-CLL). Subset #6 (IGHV1-69/IGKV3-20) is less aggressive compared to subset #8 (IGHV4-39/IGKV1(D)-39) which h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7383270f34f3bb128ef05137cffabc77
Wiley Online Library
Wiley Online Library
Autor:
Sujata Bhoi, Karin E. Smedby, Panagiotis Baliakas, Lesley-Ann Sutton, Larry Mansouri, Gunnar Juliusson, Marie Engvall, Mattias Mattsson, Diego Cortese
Publikováno v:
Haematologica. 101:e63-e65
High UGT2B17 mRNA expression has recently been correlated with poor prognosis in chronic lymphocytic leukemia (CLL).1 In the present study, we investigated the expression of UGT2B17 in a Scandinavian population-based CLL cohort (n=253) and can confir
Publikováno v:
Leukemia & Lymphoma. 54:2351-2364
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease where the majority of patients have an indolent disease course, while others may experience a far more aggressive disease, treatment failure and poor overall su
Autor:
Sujata Bhoi, Šárka Pospíšilová, Karla Plevová, Agata M. Wasik, Pradeep Kumar Kopparapu, Meena Kanduri, Giorgio Alberto Croci, Laleh S. Arabanian, Larry Mansouri, Richard Rosenquist, Marco Paulli, Birgitta Sander
Publikováno v:
Europe PubMed Central
Downregulation of miR26A1 has been reported in various B-cell malignancies; however, the mechanism behind its deregulation remains largely unknown. We investigated miR26A1 methylation and expression levels in a well-characterized series of chronic ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187a5e1d22627feb6f46708fa579ee7c
Autor:
Viktor Ljungström, Frederic Davi, Kostas Stamatopoulos, Diego Cortese, Nicholas Chiorazzi, Johan Rung, Šárka Pospíšilová, Xiao-Jie Yan, Antonia Kalushkova, Gunnar Juliusson, Karin E. Smedby, Gunilla Enblad, Jonathan C. Strefford, Karla Plevová, Sina Bondza, Lesley-Ann Sutton, Brigitta Sander, Linda Arngården, Rebeqa Gunnarsson, Anton W. Langerak, Larry Mansouri, Jimmy Larsson, Erin Young, Richard Rosenquist, Elin Falk-Sörqvist, Helena Jernberg-Wiklund, Marcus Lars Vittorio Nilsson, Alice F. Muggen, Paolo Ghia, Sujata Bhoi, Ola Söderberg, Chrysoula Belessi, Mats Hellström, Peter Lönn
Publikováno v:
The Journal of Experimental Medicine
Journal of Experimental Medicine; 212(6), pp 833-843 (2015)
Journal of Experimental Medicine; 212(6), pp 833-843 (2015)
Mansouri et al. applied targeted deep sequencing to identify mutations within NF-κB core complex genes in CLL. NFKBIE, the gene encoding the inhibitory IκBε molecule, was most frequently mutated, especially in poor-prognostic subgroups of CLL. The